
Commentary|Videos|June 10, 2026
Should There Be Greater Oversight of MRI Safety?
Author(s)Jeff Hall
In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, noted a lack of point-of-care safety requirements for MRI, a lack of state oversight, and a prevailing lack of minimum standards overall for MRI safety.
Advertisement
Advertisement
Safety in the MRI suite often comes down to self-policing by individual facilities and imaging centers, noted Tobias Gilk, MRSO, MRSE, in a recent interview with Diagnostic Imaging. While he said there are some organizations that are doing brilliant work in this regard, Gilk explained that other facilities are doing the bare minimum given a lack of minimum standards for MRI safety and appropriate oversight.
Related to this article

Catch up on the most-well viewed radiology content in October 2026.

In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.

In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),

Utilizing data from CCTA scans, the Syngo.CT Coronary Cockpit reportedly provides AI-automated analysis of coronary plaque.

In a recent interview at the HLTH USA conference, John Whyte, MD, MPH, shared his thoughts on the promise and limits of AI in health care.

Uptunity | Aneurysm reportedly identifies suspected saccular brain aneurysms larger than 3 mm on head CTA and provides quantitative comparison between exams to assess changes in known aneurysms over time.
Advertisement
Advertisement


